Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
heart failure
Posted inMetabolism, New Drugs, Regulatory
Kerendia: New Drug for Diabetic Kidney Disease
Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.
Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory
Leqvio: Newest Drug Against ‘Very Bad’ Cholesterol
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.
Posted inClinical Trials, Metabolism
Innovative Treatment for Hypertension: One Shot Every Quarter or Even Six Months
Arterial hypertension is waiting for a major pharmacological breakthrough. Hundreds of millions of people will be saved.
Posted inMetabolism, New Drugs, Regulatory
Wegovy: Most Effective Drug for Weight Loss
Semaglutide can help you lose 15% of your excess weight in a year. And even more.
